GLIMEPIRIDE INTAS glimepiride 4mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

glimepiride, Quantity: 4 mg

Available from:

Accord Healthcare Pty Ltd

INN (International Name):

Glimepiride

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate type A; povidone

Administration route:

Oral

Units in package:

30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

GLIMEPIRIDE INTAS is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (Type 2)

Product summary:

Visual Identification: White coloured oval shaped uncoated tablets with score line on one side and plain on the other side of the tablet; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2017-03-17